Expression of metallothionein‐1 and metallothionein‐2 as a prognostic marker in hepatocellular carcinoma
Authors:
- 22 August 2013
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 28 (9) , 1565-1572
Abstract
Background and Aims: Metallothionein (MT)‐1 and ‐2 are low‐molecular weight, cysteine‐rich, intracellular metal‐binding proteins involved in diverse functions, such as metal homeostasis, cell cycle progression, cell differentiation, and carcinogenesis. This study investigated the expression of MT‐1 and MT‐2 as a prognostic marker in hepatocellular carcinoma (HCC).Methods: Expression of MT‐1 and MT‐2 were evaluated immunohistochemically in tissue microarrays containing samples from 370 HCCs, 336 adjacent noncancerous livers, and 12 normal livers. The relationships between MT‐1 and MT‐2 expression and the clinicopathological parameters of HCC were assessed.Results: The expression of MT‐1 and MT‐2 was uniformly strong in the nucleus and cytoplasm of normal liver, but varied in noncancerous livers and HCCs. Loss of nuclear and cytoplasmic expression was significantly more in HCCs than in adjacent noncancerous livers (P < 0.001). The loss of nuclear expression of MT‐1 and MT‐2 was significantly correlated with high Edmondson‐Steiner grade and the presence of microvascular invasion (P < 0.05 each). Multivariate analysis showed that the loss of nuclear expression of MT‐1 and MT‐2 was an independent poor prognostic factor for both recurrence‐free survival and overall survival.Conclusions: The expression of MT‐1 and MT‐2 may play a role in HCC differentiation and carcinogenesis, and may predict prognosis in patients with HCC.Keywords
This publication has 36 references indexed in Scilit:
- Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysisInternational Journal of Oncology, 2009
- Intrahepatic gene expression profiles in chronic hepatitis B and autoimmune liver diseaseJournal of Gastroenterology, 2008
- Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinomaLaboratory Investigation, 2008
- Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinomaHepatology Research, 2007
- Metallothionein Expression Is Suppressed in Primary Human Hepatocellular Carcinomas and Is Mediated through Inactivation of CCAAT/Enhancer Binding Protein α by Phosphatidylinositol 3-Kinase Signaling CascadeCancer Research, 2007
- Self‐organizing‐map‐based molecular signature representing the development of hepatocellular carcinomaFEBS Letters, 2005
- Immunohistochemical metallothionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agentsJournal of Gastroenterology, 2004
- Metallothionein expression in patients with small cell carcinoma of the lungCancer, 2001
- Altered Expression of γ‐Glutamylcysteine Synthetase, Metallothionein and Topoisomerase I or II during Acquisition of Drug Resistance to Cisplatin in Human Ovarian Cancer CellsJapanese Journal of Cancer Research, 1997
- The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells.Environmental Health Perspectives, 1994